APPLICATION
ANDA202719
TYPE
ANDA
ORIGINAL APPROVAL
2016-04-19
LATEST ACTION
2022-11-08
ROUTE
OPHTHALMIC, TOPICAL
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
BIMATOPROSTPrescription
BIMATOPROST 0.03% · SOLUTION/DROPS · TOPICAL
Approval history
2022-11-08Labeling · Supplement 2 · standardAP
2022-11-08Labeling · Supplement 5 · standardAP
2020-08-12Labeling · Supplement 1 · standardAP
2016-04-19UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.